In: European Heart Journal, 2009, vol. 30, no. 2, p. 152-161
|
In: International Journal of Epidemiology, 2005, vol. 34, no. 4, p. 953-955
|
In: European Heart Journal, 2015, vol. 36, no. 36, p. 2438-2445
|
In: International Journal of Epidemiology, 2002, vol. 31, no. 1, p. 115-123
|
In: European Heart Journal, 2014, vol. 35, no. 12, p. 795-807
|
In: European Heart Journal, 2012, vol. 33, no. 11, p. 1334-1343
|
In: European Heart Journal, 2010, vol. 31, no. 2, p. 165-176
|
In: Circulation: Cardiovascular Interventions, 2015, vol. 8, no. 2, p. e001441
Background—Biodegradable polymers for release of antiproliferative drugs from drug-eluting stents aim to improve vascular healing. We assessed noninferiority of a novel ultrathin strut drug-eluting stent releasing sirolimus from a biodegradable polymer (Orsiro, O-SES) compared with the durable polymer Xience Prime everolimus-eluting stent (X-EES) in terms of the primary end...
|
In: European Heart Journal, 2012, vol. 33, no. 11, p. 1334-1343
Aims Late acquired incomplete stent apposition (ISA) is more common after drug- eluting stent (DES) than bare metal stent (BMS) implantation and has been associated with vascular hypersensitivity and stent thrombosis (ST). We investigated the impact of incidentally discovered ISA as assessed by intravascular ultrasound (IVUS) 8 months after DES implantation on the long-term clinical...
|
In: Journal of the American College of Cardiology: Cardiovascular Interventions, 2011, vol. 4, no. 6, p. 672-682
Objectives: This study sought to compare the efficacy of passive stent coating with titanium-nitride-oxide (TiNO) with drug-eluting stents releasing zotarolimus (ZES) (Endeavor, Medtronic, Minneapolis, Minnesota).Background: Stent coating with TiNO has been shown to reduce restenosis compared with bare-metal stents in experimental and clinical studies.Methods: In an assessor-blind noninferiority...
|